• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Sickle Cell Disease

    Male teen with basketball
    Sickle Cell Disease is a term for a group of hereditary blood disorders. Sickle Cell Disease is caused by abnormal hemoglobin, the protein in red blood cells that carries oxygen from the lungs to the tissues. People with sickle cell disease make hemoglobin S (Hb S) instead of the normal hemoglobin A. The red blood cells of persons with sickle cell disease don't last as long as 'normal' red blood cells. This results in chronic anemia.
    Also, these red blood cells become rigid and bend, taking on a 'sickle ' or crescent shape. These odd shaped cells are not flexible enough to squeeze through small blood vessels. This may result in blood vessels being blocked. The areas of the body served by those blood vessels will then be deprived of their blood circulation. This damages tissues and organs and causes pain. Organs that can be damaged include bones, kidneys, lungs and the brain.
    In the United States, sickle cell disease is found primarily in people of African ancestry. However, many other people, especially those coming from the Mediterranean, Middle East and some part of India have this disorder. The most common type of sickle cell disease is sickle cell anemia which affects more than 50,000 Americans. One in 375 African Americans is born with sickle cell anemia.

    Sickle Cell Disease should not be confused with Sickle Cell Trait.

    Sickle cell trait is not a disease. Individuals who have sickle cell trait are not ill and require no special treatment. Sickle cell trait is the carrier state for sickle cell disease. People with sickle cell trait make both normal hemoglobin (Hb A)- and hemoglobin S (Hb S). Their hemoglobin type is AS. One in 10 African Americans has sickle cell trait. Anyone considering having children should have a blood test to determine their hemoglobin type. If both parents have sickle cell trait, there is one chance in four that their baby will have sickle cell disease.
    In Maryland, all newborn babies are screened for sickle cell disease. Once a baby is identified, we try to make sure that he or she gets comprehensive follow-up care. Sickle cell disease can cause severe illness, but there are things you can do to try to stay healthy. A child with sickle cell disease should:
    1. See their pediatrician for all check ups and be seen right away if they get a fever (temperature greater than 101.5 F).
    2. Get all of their shots on time, and extra pneumococcal and meningococcal shots starting at 2 years of age.
    3. Take penicillin twice a day at least until they are 6 years old.
    4. Get a flu shot every year.
    5. See a hematologist (blood disorder specialist) when diagnosed and at least once a year.
    6. Get yearly eye exams and a special test (transcranial doppler or TCD) once a year to to check for stroke risk.
    The leading cause of death in children with sickle cell disease in the United States is infection. Giving young children with sickle cell disease penicillin every day and giving them special immunizations can prevent most of the infections and dramatically reduce the death rate. Maryland has the lowest death rate in the United States among children with sickle cell disease.
    We do not have complete information on how long people with sickle cell disease can expect to live. The reported average life span is 42 years for men and 48 for women. Treatment for the symptoms of sickle cell disease has improved over the years and many people with sickle cell disease are living beyond middle age, holding jobs, and carrying out family responsibilities. We know some patients in their 70's and 80's.  Further information can be found at link www.scinfo.org.

    Newborn Screening in Maryland

    There were approximately 2,496 infants identified with Sickle Cell 
    Disease (SCD) via Newborn Screening in Maryland from 1995 through 2016.
    • From 2012-2016, 475 newborns were diagnosed with SCD; an average of 97 infants per year.
    • 97% of those diagnosed were African American.
    • SCD occurs among approximately 1 out of every 767 births in Maryland.
    • SCD occurs among approximately 1 out of every 256 African American births in Maryland.
    • Currently, there are 2,168 children ages 0-18 years old born in Maryland with SCD (including all variations of SCD).